(Q56898222)

4

M C Weinstein

0 references

A. David Paltiel

1

A D Paltiel

0 references

Kenneth A. Freedberg

8

K A Freedberg

0 references

April D. Kimmel

6

A D Kimmel

0 references

author name string

S J Goldie

2

0 references

G R Seage

5

0 references

H Zhang

Clinical Infectious Diseases

7

0 references

language of work or name

English

0 references

publication date

1 March 2001

0 references

published in

0 references

volume

32

0 references

issue

5

0 references

page(s)

783-93

0 references

cites work

Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

Cost-effectiveness of cytomegalovirus (CMV) disease prevention in patients with AIDS: oral ganciclovir and CMV polymerase chain reaction testing

21 January 2018

1 reference

The cost-effectiveness of preventing AIDS-related opportunistic infections

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome

21 January 2018

1 reference

Cytomegalovirus reactivation in patients infected with HIV: the use of polymerase chain reaction in prediction and management

21 January 2018

1 reference

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

21 January 2018

1 reference

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

21 January 2018

1 reference

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

21 January 2018

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

21 January 2018

1 reference

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

21 January 2018

1 reference

The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group

21 January 2018

1 reference

Random-effects models for longitudinal data

21 January 2018

1 reference

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

21 January 2018

1 reference

Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning

21 January 2018

1 reference

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS.

21 January 2018

1 reference

Survival from early, intermediate, and late stages of HIV infection

21 January 2018

1 reference

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

21 January 2018

1 reference

Effect of an Explicit Decision-Support Tool on Decisions to Prescribe Antibiotics for Sore Throat

21 January 2018

1 reference